Browse Categories
Browse by Date
- 2021
- July
- June
- May
- April
- March
- February
- January
- 2020
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2019
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2018
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2017
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2016
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2015
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2014
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2013
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2012
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
Report: Interoperability does not affect EHR buying decision
Healthcare research firm KLAS reports that healthcare providers remain strongly concerned about interoperability of technology from various vendors and "strongly encourage better coordination among vendors, timely location of patient records and greatly improved parsing...
New bipartisan House legislation aims to boost the amount of shared savings that accountable care organizations can receive from the federal government to halt a slide in participation that has occurred over the past two years. The...
In a joint letter to the four representatives who introduced the bill in the House of Representatives, payer and provider organizations have thrown their support behind the Value in Health Care Act of 2021 which seeks to bolster Medicare...
Albiero Pharma Inc. announced it received FDA approval for Bylvay to treat pruritus in all subtypes of progressive familial intrahepatic cholestasis. According to a press release, it is the first drug approved for PFIC. Bylvay...
The U.S. Food and Drug Administration has approved AztraZeneca’s BYDUREON BCise once-weekly injectable suspension for use in children aged 10 to 17 years for the treatment of type 2 diabetes. The treatment should be used in addition to a diet and exercise plan.
After having thrived in a fee-for-service healthcare system, can chronic disease specialists be enticed to switch? Specialists are key partners for delivering value-based care, particularly for patients with chronic diseases. This involves the appropriate diagnosis of conditions,...
Insurers make acquisitions as pandemic adoption of virtual care delivery becomes the norm. As health insurers and retailers focus on meeting patients’ demands to have access to healthcare when they want it, how they want it, telehealth acquisitions and expansions...
RECOMMENDED:
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
